Form 603, “Notice of initial substantial holder” was lodged with the Australian Securities Exchange on 30th January at 5:29 PM.
View the form 603.
The Stock Network Interview – How MagSense® is moving towards Phase 2 clinical trials
September 4, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how the company is moving through the critical steps required